Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Johnson & Johnson (

Les Squires obituary

Other lives: Non-woven fabrics designer who created new materials for use in industry and agriculture

The Guardian - UK

3 Top Dividend Stocks Analysts Are Bullish on Right Now

With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support

MarketBeat

Johnson & Johnson Stock: Is JNJ Outperforming the Healthcare Sector?

Johnson & Johnson has outpaced the broader healthcare sector over the past year, and analysts remain optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Build a Bulletproof Dividend Portfolio With These 5 Defensive Stocks

These defensive stocks pay reliable dividends.

Barchart

New documentary explores the Tylenol cyanide murders - and the reason tamper-proof seals are on everything

In 1982, seven people in Chicago died after taking Tylenol laced with lethal cyanide, causing fear and a change in consumer product safety. Two suspects emerged but there were no arrests or answers. Now, a new Netflix docuseries, out May 26, examines the decades-old mystery offering an exclusive interview with…

The Independent UK

‘A new form of mass murder’: the terrifying, twisty unsolved mystery of the Tylenol killer

One of the most shocking true crime stories of the 80s is re-investigated in Netflix docuseries Cold Case: The Tylenol Murders

The Guardian - US

3 Buy-and-Hold Stocks Long-Term Investors Can Love in Any Market

For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

2 Companies Now Have Credit Ratings Higher Than The U.S.

The U.S. may have just lost its AAA rating — but at least there are still financially responsible U.S. companies left.

Investors Business Daily

Kenvue Fights to Shield Brands Like Listerine and Tylenol Amid £112m Tariff Shock

Kenvue customers are expected to be prepared for price hikes as companies that sell directly to consumers grapple with rising costs.

International Business Times UK

Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News

Halozyme Therapeutics shares tumbled Tuesday on a new Medicare approach to price negotiations for drugs that use additive products.

Investors Business Daily

Trump hints at tariff reprieve for pharma companies that bring operations back to US

He suggests drugmakers would get ‘a lot of time’ to repatriate manufacturing before facing levies

The Guardian - UK

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug

Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment.

Investors Business Daily

3 Industry Behemoths Are Rewarding Investors With Dividend Bumps

See these three stocks that are among the most important in their industries, which have announced sizable increases in their dividends.

MarketBeat

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

The stock market sold off this week, with Nvidia AI chip export curbs, UnitedHealth guidance and Fed chief Jerome Powell's comments in focus.

Fortune

Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson

As recession fears mount on Wall Street, management is still reportedly setting ambitious long-term goals.

MarketBeat

Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?

Johnson & Johnson had more good than bad; investors should look at the entire report in context before deciding if JNJ stock is a good fit for their portfolios

The Independent UK

Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds

Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its 2025 sales guidance.

Investors Business Daily

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Pharma names whipsawed Wednesday after Trump said he would enact "major" tariffs on drug imports and then backed off his tariffs — for now.

The Guardian - UK

‘Half the place would be blown to bits’: the Irish villages under threat from Trump’s tariffs

Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on the sector

Euronews

Did pharma sector dodge Trump’s tariffs? The EU's not so sure

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission remains on guard, considering further tariff deployments likely.

Investors Business Daily

Stock Market Today: Dow Jones Soars As Trump Tariffs Loom; Tesla Jumps On Musk Reports As Amazon Joins TikTok Bidding War (Live Coverage)

Tesla sank in the stock market today after it reported first quarter deliveries.

Kiplinger

Stock Market Today: Stocks Are Mixed Before Liberation Day

Markets are getting into the freewheeling rhythm of a second Trump administration.

Investors Business Daily

J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan

Johnson & Johnson stock slumped Tuesday after a judge rejected its $10 billion proposal to settle thousands of talc-tied lawsuits.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations